Biotechnological Approaches to Discovery of Drugs for Veterinary Use

This review examined the application of biotechnology to veterinary drug discovery, highlighting its efficiency and potential for creating novel therapies for a wide range of animal diseases. Compared to conventional methods, biotechnological models offer several advantages, such as reduced time and cost. These models also allowed for an abysmal empathetic of disease mechanisms, facilitating the development of highly targeted treatments. Gene therapy is a significant area of research, demonstrating considerable potential in addressing various veterinary conditions. Its successful application includes the management of ocular disorders in dogs, cardiovascular and renal issues in cats, osteoarthritis in horses, and metabolic disorders like diabetes in dogs. Advances in genome sequencing and proteomics have enabled researchers to understand animal proteomes better, leading to the documentation of potential drug targets and the development of more precise therapies. vetinformatics, which uses computational tools and big data analysis, is vital for accelerating research and development in veterinary science. The convergence of biotechnology and Artificial Intelligence (AI) presents considerable promise for the future of veterinary drug discovery. AI-powered algorithms can analyses large datasets, identify patterns, and predict drug efficacy, thus expediting the drug development process and creating more effective treatments. Continued investment in these areas is essential to realize the transformative potential of biotechnology for improving animal health and advancing veterinary science.